Case Report
Copyright ©2012 Baishideng. All rights reserved.
World J Dermatol. Oct 2, 2012; 1(3): 38-40
Published online Oct 2, 2012. doi: 10.5314/wjd.v1.i3.38
Primary cutaneous anaplastic large cell lymphoma with subsequent leg involvement
Mitsuaki Ishida, Norikazu Fujii, Hidetoshi Okabe
Mitsuaki Ishida, Hidetoshi Okabe, Division of Diagnostic Pathology, Department of Clinical Laboratory Medicine, Shiga University of Medical Science, Shiga 520-2192, Japan
Norikazu Fujii, Department of Dermatology, Shiga University of Medical Science, Shiga 520-2192, Japan
Author contributions: Ishida M interpreted the data and wrote the manuscript; all authors contributed to analyzing the patient’s data.
Correspondence to: Mitsuaki Ishida, MD, PhD, Assistant Professor, Division of Diagnostic Pathology, Department of Clinical Laboratory Medicine, Shiga University of Medical Science, Tsukinowa-cho, Seta, Otsu, Shiga 520-2192, Japan. mitsuaki@belle.shiga-med.ac.jp
Telephone: +81-77-5482603 Fax: +81-77-5482407
Received: October 31, 2011
Revised: July 13, 2012
Accepted: September 26, 2012
Published online: October 2, 2012
Abstract

Primary cutaneous anaplastic large cell lymphoma (C-ALCL) is regarded as an indolent type of cutaneous T-cell lymphoma. However, a few recent publications revealed that C-ALCL patients with initial leg involvement had significantly worse survival than those without initial leg involvement. Herein, we report a case of C-ALCL with subsequent leg involvement, which led to death after chemoradiation therapy. A 75 years old Japanese man presented with multiple erythematous nodules in his left arm and the side of his left chest. Histopathological and immunohistochemical studies led to the diagnosis of primary C-ALCL. At the initial diagnosis, no leg lesion was found. One year after the initial diagnosis, C-ALCL appeared in his right lower thigh and left hip. Radiation therapy, low-dose etoposide and CHOP therapy were performed; however, the patient died of malignant lymphoma 4 years after the initial diagnosis. We speculated that the occurrence of subsequent leg involvement may also be indicative of a worse prognosis, as in the case with initial leg involvement in C-ALCL. Therefore, we propose that C-ALCL patients with initial or subsequent leg involvement should be classified as a distinct clinicopathological variant of C-ALCL (“leg-type” involvement) and that they may require intense therapy.

Keywords: Cutaneous lymphoma; Cutaneous CD30-positive T-cell lymphoproliferative lesion; Primary cutaneous anaplastic large cell lymphoma; Leg involvement; Prognosis; Chemotherapy